Related Experiment Videos
TSH may not be a good marker for adequate thyroid hormone replacement therapy
Maria Alevizaki1, Emily Mantzou, Adriana T Cimponeriu
1Endocrine Unit, Dept Medical Therapeutics, Alexandra Hospital, Athens University School of Medicine, Athens, Greece. mani@OTENET.gr
Wiener Klinische Wochenschrift
|January 18, 2006
Summary
Thyroid hormone replacement therapy (T4) in hypothyroidism may not fully restore triiodothyronine (T3) levels or peripheral thyroid hormone action, suggesting potential tissue hypothyroidism. Current TSH monitoring may be insufficient for optimal treatment.
Area of Science:
- Endocrinology
- Thyroidology
Background:
- Levothyroxine (T4) therapy is standard for hypothyroidism.
- Current treatment criteria rely on normalized thyroid-stimulating hormone (TSH) levels.
- Peripheral thyroid hormone action may not be fully assessed by TSH alone.
Purpose of the Study:
- To evaluate thyroid function and peripheral hormone action in well-controlled hypothyroid patients.
- To compare T4-treated hypothyroid patients with euthyroid controls.
- To investigate the adequacy of T4 monotherapy in achieving comprehensive thyroid hormone balance.
Main Methods:
- Compared 85 T4-treated hypothyroid patients (28 athyric) with 114 normal individuals matched for TSH.
- Measured thyroid hormone levels (T3, T4, fT4) and sex hormone-binding globulin (SHBG).
- Analyzed correlations between TSH and T3, and regression slopes for T3/TSH.
Main Results:
- Hypothyroid patients had lower T3 and SHBG levels despite higher T4 and fT4.
- These differences persisted even with stricter TSH control (TSH < 2.5 microU/ml).
- Lower T3 levels were observed at equivalent TSH levels in hypothyroid patients compared to controls.
Conclusions:
- T4 therapy in hypothyroidism results in lower T3, T3/T4 ratio, and SHBG compared to euthyroid individuals with similar TSH.
- This suggests potential relative tissue hypothyroidism, particularly in the liver.
- TSH may not be a perfect marker for adequate thyroid hormone action in all tissues; T3 co-administration or aiming for low-normal TSH is recommended.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...